UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029134
Receipt number R000033305
Scientific Title Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy
Date of disclosure of the study information 2017/09/14
Last modified on 2019/02/21 17:18:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy

Acronym

Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy

Scientific Title

Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy

Scientific Title:Acronym

Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy

Region

Japan


Condition

Condition

According to the diagnostic criteria for mood (affective) disorders:ICD-10

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the effect of impedance-reduction between PreTac(skin preparatory solution to remove sebum) and Grad Z-101BA(salt-infused gel applied between electric pad and skin).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Static impedance (measured with 6 microampere) at placing electrodes on the patient skin and dynamic impedance (measured with 0.9 ampere) during administrating electric current to the brain.

Key secondary outcomes

Number of times spent with saimapad
and Postictal Suppression Index (decrease in value immediately after the attack, completed average amplitude of 3 seconds between viewed in percent as reduced the average amplitude of the maximum amplitude of the seizure during 3 seconds, which one of the indicators of the quality of the attack)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Installing using drugs used saimapad in modified electroconvulsive therapy in the study subjects 10.
The modified electroconvulsive therapy and other enforcement procedures there is no difference.
(1) odd times:PreTac liquid
(2) even once: Grad Z-101BA

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Study participants shall meet all the following criteria.
(1)Persons diagnosed with F3 mood (affective) disorders ICD-10 diagnostic criteria using
(2)Persons wearing saimapad on the bilateral side head, carried a modified electroconvulsive therapy
(3)Agree to the proposed person or obtained from the Novotel (spouse, brothers and sisters, his lineal relative within the relatives, guardian or curator shall)

Key exclusion criteria

Otherwise excluded from study participants.
(1) if the person or from the Novotel was discontinued participation in research proposal
(2) in the PreTac fluid and Gerad Z-101BA until now or further if any allergic symptoms

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hitoshi Miyaoka

Organization

Kitasato University East hospital

Division name

Department of Psychiatry

Zip code


Address

2-1-1 Asamizodai,Minami-ku, Sagamihara-shi, Kanagawa 252-0380, Japan

TEL

042-748-9111

Email

miyaoka@med.kitasato-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoya Shimano

Organization

Kitasato University East hospital

Division name

Department of Psychiatry

Zip code


Address

2-1-1 Asamizodai,Minami-ku, Sagamihara-shi, Kanagawa 252-0380, Japan

TEL

042-748-9111

Homepage URL


Email

dm17013@st.kitasato-u.ac.jp


Sponsor or person

Institute

Department of Pychiatry, Kitasato University East hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Pychiatry, Kitasato University East hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北里大学東病院(神奈川県)/ Kitasato University East hospital (Kanagawa Prefecture


Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 11 Month 22 Day

Last follow-up date

2019 Year 02 Month 21 Day

Date of closure to data entry

2019 Year 02 Month 21 Day

Date trial data considered complete

2019 Year 02 Month 21 Day

Date analysis concluded

2019 Year 02 Month 21 Day


Other

Other related information



Management information

Registered date

2017 Year 09 Month 13 Day

Last modified on

2019 Year 02 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033305


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name